Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease.

Silver RM, Wilson DA, Akter T, Atanelishvili I, Huggins JT, Kajdasz K, Highland KB, Nietert PJ, Bogatkevich GS.

ACR Open Rheumatol. 2019 Aug 6;1(7):403-411. doi: 10.1002/acr2.11049. eCollection 2019 Sep.

2.

The Impact of Gravity vs Suction-driven Therapeutic Thoracentesis on Pressure-related Complications: The GRAVITAS Multicenter Randomized Controlled Trial.

Lentz RJ, Shojaee S, Grosu HB, Rickman OB, Roller L, Pannu JK, DePew ZS, Debiane LG, Cicenia JC, Akulian J, Walston C, Sanchez TM, Davidson KR, Jagan N, Ahmad S, Gilbert C, Huggins JT, Chen H, Light RW, Yarmus L, Feller-Kopman D, Lee H, Rahman NM, Maldonado F; Interventional Pulmonary Outcomes Group.

Chest. 2019 Nov 9. pii: S0012-3692(19)34190-X. doi: 10.1016/j.chest.2019.10.025. [Epub ahead of print]

PMID:
31711990
3.

The Relationship of Pleural Manometry With Postthoracentesis Chest Radiographic Findings in Malignant Pleural Effusion.

Chopra A, Judson MA, Doelken P, Maldonado F, Rahman NM, Huggins JT.

Chest. 2020 Feb;157(2):421-426. doi: 10.1016/j.chest.2019.08.1920. Epub 2019 Aug 28.

PMID:
31472154
4.

Point-of-Care Echocardiography Unveils Misclassification of Acute Kidney Injury as Hepatorenal Syndrome.

Velez JCQ, Petkovich B, Karakala N, Huggins JT.

Am J Nephrol. 2019;50(3):204-211. doi: 10.1159/000501299. Epub 2019 Aug 8.

PMID:
31394538
5.

Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials.

Wuyts W, Antin-Ozerkis D, Huggins JT, LaCamera PP, Spagnolo P, Vašáková M, Wijsenbeek MS, Polman B, Kirchgaessler KU, Scholand MB.

Respir Med. 2019 Apr;150:120-125. doi: 10.1016/j.rmed.2019.02.021. Epub 2019 Mar 13.

6.

Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial.

Lentz RJ, Lerner AD, Pannu JK, Merrick CM, Roller L, Walston C, Valenti S, Goddard T, Chen H, Huggins JT, Rickman OB, Yarmus L, Psallidas I, Rahman NM, Light RW, Maldonado F.

Lancet Respir Med. 2019 May;7(5):447-455. doi: 10.1016/S2213-2600(18)30421-1. Epub 2019 Feb 13.

PMID:
30772283
7.

Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis.

Brown KK, Flaherty KR, Cottin V, Raghu G, Inoue Y, Azuma A, Huggins JT, Richeldi L, Stowasser S, Stansen W, Schlenker-Herceg R, Maher TM, Wells AU.

Respir Med. 2019 Jan;146:42-48. doi: 10.1016/j.rmed.2018.11.012. Epub 2018 Nov 19.

8.

Acute exacerbations of progressive-fibrosing interstitial lung diseases.

Kolb M, Bondue B, Pesci A, Miyazaki Y, Song JW, Bhatt NY, Huggins JT, Oldham JM, Padilla ML, Roman J, Shapera S.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180071. doi: 10.1183/16000617.0071-2018. Print 2018 Dec 31. Review.

9.

Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.

Crestani B, Huggins JT, Kaye M, Costabel U, Glaspole I, Ogura T, Song JW, Stansen W, Quaresma M, Stowasser S, Kreuter M.

Lancet Respir Med. 2019 Jan;7(1):60-68. doi: 10.1016/S2213-2600(18)30339-4. Epub 2018 Sep 14.

PMID:
30224318
10.

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.

Flaherty KR, Fell CD, Huggins JT, Nunes H, Sussman R, Valenzuela C, Petzinger U, Stauffer JL, Gilberg F, Bengus M, Wijsenbeek M.

Eur Respir J. 2018 Aug 2;52(2). pii: 1800230. doi: 10.1183/13993003.00230-2018. Print 2018 Aug. Erratum in: Eur Respir J. 2018 Oct 4;52(4):.

11.

Unexpandable lung from pleural disease.

Huggins JT, Maldonado F, Chopra A, Rahman N, Light R.

Respirology. 2018 Feb;23(2):160-167. doi: 10.1111/resp.13199. Epub 2017 Oct 24. Review.

PMID:
29064169
12.

The Urinothorax: A Comprehensive Review With Case Series.

Austin A, Jogani SN, Brasher PB, Argula RG, Huggins JT, Chopra A.

Am J Med Sci. 2017 Jul;354(1):44-53. doi: 10.1016/j.amjms.2017.03.034. Epub 2017 Apr 7. Review.

PMID:
28755732
13.

Concordant and Discordant Exudates and Their Effect on the Accuracy of Light's Criteria to Diagnose Exudative Pleural Effusions.

Ferreiro L, Sánchez-Sánchez R, Valdés L, Kummerfeldt CE, Huggins JT.

Am J Med Sci. 2016 Dec;352(6):549-556. doi: 10.1016/j.amjms.2016.08.016. Epub 2016 Sep 28.

PMID:
27916209
14.

The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions.

Svigals PZ, Chopra A, Ravenel JG, Nietert PJ, Huggins JT.

Thorax. 2017 Jan;72(1):94-95. doi: 10.1136/thoraxjnl-2016-208904. Epub 2016 Sep 9.

15.

First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value.

Wuyts WA, Kolb M, Stowasser S, Stansen W, Huggins JT, Raghu G.

Lung. 2016 Oct;194(5):739-43. doi: 10.1007/s00408-016-9912-1. Epub 2016 Jul 4.

16.

Point-of-Care Echocardiography Improves Assessment of Volume Status in Cirrhosis and Hepatorenal Syndrome.

Huggins JT, Doelken P, Walters C, Rockey DC.

Am J Med Sci. 2016 May;351(5):550-3. doi: 10.1016/j.amjms.2016.02.040. Epub 2016 Mar 2.

PMID:
27140719
17.

83-Year-Old Man With Chronic Kidney Disease, Fluid Overload, and Coronary Artery Disease Develops Altered Mental Status.

Bade BC, Callahan SP, Higuero JP, Pastis N, Huggins JT.

Chest. 2016 Apr;149(4):e111-4. doi: 10.1016/j.chest.2015.11.032. No abstract available.

PMID:
27055714
18.

Pleural Fluid Analysis in Chronic Hemothorax: A Mimicker of Infection.

DiVietro ML, Huggins JT, Angotti LB, Kummerfeldt CE, Nestor JE, Doelken P, Sahn SA.

Clin Med Insights Case Rep. 2015 Aug 10;8:71-6. doi: 10.4137/CCRep.S12404. eCollection 2015.

19.

Construct validity of the Simbionix bronch mentor simulator for essential bronchoscopic skills.

Pastis NJ, Vanderbilt AA, Tanner NT, Silvestri GA, Huggins JT, Svigals Z, Shepherd RW.

J Bronchology Interv Pulmonol. 2014 Oct;21(4):314-21. doi: 10.1097/LBR.0000000000000111.

PMID:
25321450
20.

Characteristics of patients with yellow nail syndrome and pleural effusion.

Valdés L, Huggins JT, Gude F, Ferreiro L, Alvarez-Dobaño JM, Golpe A, Toubes ME, González-Barcala FJ, José ES, Sahn SA.

Respirology. 2014 Oct;19(7):985-92. doi: 10.1111/resp.12357. Epub 2014 Aug 14. Review.

21.

A 37-year-old woman with diabetes mellitus, systemic hypertension, and chronic kidney disease admitted with multifocal pneumonia and empyema.

Huggins JT, Karakala N, Campbell R, Kummerfeldt C, Nestor J, Pastis NJ, Doelken P.

Chest. 2014 Aug;146(2):e41-e46. doi: 10.1378/chest.13-2711. No abstract available.

PMID:
25091761
22.

A drag reducing surfactant threadlike micelle system with unusual rheological responses to pH.

Shi H, Ge W, Wang Y, Fang B, Huggins JT, Russell TA, Talmon Y, Hart DJ, Zakin JL.

J Colloid Interface Sci. 2014 Mar 15;418:95-102. doi: 10.1016/j.jcis.2013.11.078. Epub 2013 Dec 8.

PMID:
24461823
23.

Improving the predictive accuracy of identifying exudative effusions.

Kummerfeldt CE, Chiuzan CC, Huggins JT, DiVietro ML, Nestor JE, Sahn SA, Doelken P.

Chest. 2014 Mar 1;145(3):586-592. doi: 10.1378/chest.13-1142.

PMID:
24008773
24.

Pulmonary capillaritis in a patient with moderately positive anti-PL-12 antibodies.

Kummerfeldt CE, Huggins JT, Riemer EC, Ravenel JG, Whelan TP, Sahn SA.

Int J Rheum Dis. 2013 Apr;16(2):233-4. doi: 10.1111/1756-185X.12058. Epub 2013 Apr 4. No abstract available.

PMID:
23773650
25.

Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone?

Sahn SA, Huggins JT, San José ME, Álvarez-Dobaño JM, Valdés L.

Int J Tuberc Lung Dis. 2013 Jun;17(6):787-93. doi: 10.5588/ijtld.12.0892.

PMID:
23676163
26.

Effects of coexisting pneumonia and end-stage renal disease on pleural fluid analysis in patients with hydrostatic pleural effusion.

Doelken P, Huggins JT, Goldblatt M, Nietert P, Sahn SA.

Chest. 2013 Jun;143(6):1709-1716. doi: 10.1378/chest.12-2221.

27.

Photoreversible micellar solution as a smart drag-reducing fluid for use in district heating/cooling systems.

Shi H, Ge W, Oh H, Pattison SM, Huggins JT, Talmon Y, Hart DJ, Raghavan SR, Zakin JL.

Langmuir. 2013 Jan 8;29(1):102-9. doi: 10.1021/la304001r. Epub 2012 Dec 19.

PMID:
23210742
28.

Parasitic diseases of the pleura.

Lal C, Huggins JT, Sahn SA.

Am J Med Sci. 2013 May;345(5):385-9. doi: 10.1097/MAJ.0b013e318266e984. Review.

PMID:
22990049
29.

Unusual bacterial infections and the pleura.

Kummerfeldt CE, Huggins JT, Sahn SA.

Open Respir Med J. 2012;6:75-81. doi: 10.2174/1874306401206010075. Epub 2012 Sep 6.

30.

Intrapleural therapy.

Huggins JT, Doelken P, Sahn SA.

Respirology. 2011 Aug;16(6):891-9. doi: 10.1111/j.1440-1843.2011.02011.x. Review.

PMID:
21672085
31.

Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer.

Wang Memoli JS, El-Bayoumi E, Pastis NJ, Tanner NT, Gomez M, Huggins JT, Onicescu G, Garrett-Mayer E, Armeson K, Taylor KK, Silvestri GA.

Chest. 2011 Dec;140(6):1550-1556. doi: 10.1378/chest.11-0252. Epub 2011 Jun 2.

32.

Pleural fluid analysis and radiographic, sonographic, and echocardiographic characteristics of hepatic hydrothorax.

Gurung P, Goldblatt M, Huggins JT, Doelken P, Nietert PJ, Sahn SA.

Chest. 2011 Aug;140(2):448-453. doi: 10.1378/chest.10-2134. Epub 2011 Jan 27.

33.

Chylothorax and cholesterol pleural effusion.

Huggins JT.

Semin Respir Crit Care Med. 2010 Dec;31(6):743-50. doi: 10.1055/s-0030-1269834. Epub 2011 Jan 6. Review.

PMID:
21213206
34.

The unexpandable lung.

Huggins JT, Doelken P, Sahn SA.

F1000 Med Rep. 2010 Oct 21;2:77. doi: 10.3410/M2-77.

35.

Dasatinib-induced pleural effusions: a lymphatic network disorder?

Goldblatt M, Huggins JT, Doelken P, Gurung P, Sahn SA.

Am J Med Sci. 2009 Nov;338(5):414-7. doi: 10.1097/MAJ.0b013e3181ae9227.

PMID:
19838099
36.

A 56-year-old woman with arm pain, dyspnea, and an elevated diaphragm.

Kalluri M, Huggins JT, Strange C.

Chest. 2008 Jan;133(1):296-9. doi: 10.1378/chest.07-0721. No abstract available.

PMID:
18187758
37.
38.

Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT.

Huggins JT, Sahn SA, Heidecker J, Ravenel JG, Doelken P.

Chest. 2007 Jan;131(1):206-13.

PMID:
17218577
39.

Pathophysiology of pneumothorax following ultrasound-guided thoracentesis.

Heidecker J, Huggins JT, Sahn SA, Doelken P.

Chest. 2006 Oct;130(4):1173-84.

PMID:
17035453
40.

Pleural effusions in a series of 181 outpatients with sarcoidosis.

Huggins JT, Doelken P, Sahn SA, King L, Judson MA.

Chest. 2006 Jun;129(6):1599-604.

PMID:
16778281
41.

Pleural manometry.

Huggins JT, Doelken P.

Clin Chest Med. 2006 Jun;27(2):229-40. Review.

PMID:
16716815
42.

Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.

Almoosa KF, Ryu JH, Mendez J, Huggins JT, Young LR, Sullivan EJ, Maurer J, McCormack FX, Sahn SA.

Chest. 2006 May;129(5):1274-81.

PMID:
16685019
43.

Causes and management of pleural fibrosis.

Huggins JT, Sahn SA.

Respirology. 2004 Nov;9(4):441-7. Review.

PMID:
15612954
44.

Pleural manometry: technique and clinical implications.

Doelken P, Huggins JT, Pastis NJ, Sahn SA.

Chest. 2004 Dec;126(6):1764-9.

PMID:
15596671
45.

Eucalyptus as a specific irritant causing vocal cord dysfunction.

Huggins JT, Kaplan A, Martin-Harris B, Sahn SA.

Ann Allergy Asthma Immunol. 2004 Sep;93(3):299-303.

PMID:
15478393
46.

Management of secondary spontaneous pneumothorax: there's confusion in the air.

Heffner JE, Huggins JT.

Chest. 2004 Apr;125(4):1190-2. No abstract available.

PMID:
15078722
47.

Drug-induced pleural disease.

Huggins JT, Sahn SA.

Clin Chest Med. 2004 Mar;25(1):141-53. Review.

PMID:
15062606
48.

Duro-pleural fistula diagnosed by beta2-transferrin.

Huggins JT, Sahn SA.

Respiration. 2003 Jul-Aug;70(4):423-5.

PMID:
14512681

Supplemental Content

Loading ...
Support Center